Home›Stock Screener›Vivo Bio Tech›Quarterly Results

Vivo Bio Tech Quarterly Results

Latest Quarter Net Profit
₹-5 Cr
QMar 2026
Quarterly Results

Vivo Bio Tech quarterly results. In Mar 2026, Vivo Bio Tech (VIVOBIOT) reported revenue ₹14 Cr and net profit ₹-5 Cr — revenue +16.7% YoY. Review VIVOBIOT P/E comparison to evaluate earnings-based valuation against sector peers.

VIVOBIOT Quarterly Results — Revenue, Profit & EPS Highlights

Vivo Bio Tech latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Check VIVOBIOT market value to track the company's total market size over time.

  • Revenue of ₹14 Cr in Mar 2026 (+0.0% vs Jun 2026, +16.7% vs Mar 2025)
  • Net Profit of ₹-5 Cr in Mar 2026 (-600.0% vs Mar 2025)
  • EBITDA of ₹5 Cr in Mar 2026 (+0.0% vs Jun 2026)
  • Operating Margin of 31.0% in Mar 2026 (-4.0pp vs Jun 2026)
  • Earnings Per Share of ₹-2.52 in Mar 2026 (-3250.0% vs Jun 2026)

Vivo Bio Tech Quarterly Results — Revenue, EBITDA, Net Profit & EPS

VIVOBIOT quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 14 14 13 12 13 - 16.7%
Net Profit (₹ Cr) -5 0 1 1 1 - -
EBITDA (₹ Cr) 5 5 6 5 6 - -
EPS (₹) -2.52 0.08 0.45 0.69 0.74 - -
Operating Margin (%) 31.0% 35.0% 41.0% 41.0% 44.0% - -

VIVOBIOT Share Price Trend — 1-Year Movement Across Quarterly Results

Vivo Bio Tech 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit Vivo Bio Tech share price chart.

Profitability Ratios

Profit Margin -35.7%
EBITDA Margin 35.7%
Operating Margin 31.0%
ROE (Annual) -21.5%

Balance Sheet Highlights

Total Assets ₹178 Cr
Total Equity ₹93 Cr
Current Assets ₹28 Cr
Current Liabilities ₹55 Cr

Cash Flow Analysis

Operating Cash Flow ₹35 Cr
Investing Cash Flow ₹-59 Cr
Financing Cash Flow ₹25 Cr
Net Cash Flow ₹0 Cr

Current Market Data

Current Price ₹15.14
Exchange NSE
Last Updated Oct 05, 2026

Revenue Trend (₹ Cr)

Mar 2025 12
Sept 2025 13
Jun 2026 14
Mar 2026 14

Net Profit Trend (₹ Cr)

Mar 2025 1
Sept 2025 1
Jun 2026 0
Mar 2026 -5

Operating Margin Trend (%)

Mar 2025 41.0%
Sept 2025 41.0%
Jun 2026 35.0%
Mar 2026 31.0%

VIVOBIOT vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Vivo Bio Tech latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹432,120.23 Cr 1779.7 15,018 2,710 -5.6% - 18.0% 157.5
Divis Laboratories
Mar 2026 		₹253,522.49 Cr 9196.0 2,986 751 -5.0% - 25.2% 324.8
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4772.0 4,111 364 +27.7% +42.2% 8.9% 414.6
Zydus Life Science
Mar 2026 		₹113,615.69 Cr 1139.0 7,569 1,341 -4.3% - 17.7% 90.0
Cipla
Mar 2026 		₹108,576.18 Cr 1335.5 6,612 543 -9.3% - 8.2% 194.4
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores